Inflammation-induced hepcidin can induce transient hyposideremia, anemia, and disease outcomes in acute-phase KD (Figure 1), and further insightful research is required to better clarify the role of hepcidin in the pathogenesis of KD. The gene discussed is HAMP; the disease is anemia.